Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Spyre Therapeutics Inc (SYRE)
Spyre Therapeutics Inc (SYRE) Financials

SYRE Spyre Therapeutics Inc

23.51

-0.72 (-2.97%)

26 Jun 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-41.049	-44.236	-66.282	-97.257	-66.089	-48.464	-92.577	-164.062
Return on Equity (%)	-106.47	-48.076	-75.316	-122.743	-80.928	-58.81	-124.868	-289.167
Return on Invested Capital (%)	-107.649	-48.971	-77.395	-127.536	-82.895	-59.792	-130.079	-163.595
Operating Margin (%)	-468.842	-523.266	-1140.638	N/A	N/A	-350.392	-3604.594	-38241.084
Net Profit Margin (%)	-468.842	-523.266	-1140.638	N/A	N/A	-351.145	-3598.755	-38238.149
Book Value Per Share	2.129	1.534	1.674	1.328	2.181	1.282	0.648	13.299
Earnings Per Share	-0.734	-0.83	-1.101	-1.73	-1.262	-1.005	-1.079	-16.776
Cash Per Share	1.614	0.391	0.558	0.426	1.405	0.231	0.449	9.353
Working Capital Per Share	2.112	1.504	1.649	1.241	2.08	1.202	0.613	15.328
Operating Profit Per Share	0.156	0.159	0.097	N/A	N/A	0.286	0.03	0.044
EBIT Per Share	-0.734	-0.83	-1.101	-1.73	-1.262	-1.002	-1.081	-16.777
EBITDA Per Share	-0.734	-0.83	-1.101	-1.73	-1.262	-1.002	-1.081	-16.777
Free Cash Flow Per Share	-0.731	-0.819	-1.098	-1.706	-1.211	-1.02	-1.097	-16.813

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	16.753	9.769	7.488	4.058	9.11	4.909	4.248	10.68
Quick Ratio	16.322	9.483	7.277	3.919	8.896	4.623	3.801	10.61
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	13.43M	16.67M	24.14M	29.08M	47.96M	49.36M	N/A	N/A

Key Stats and Ratios

Year End 31 December 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	61.51M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-9322.222	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	-9304.04	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	3.512	N/A	N/A	N/A	11.38
Quick Ratio	N/A	N/A	N/A	3.071	N/A	N/A	N/A	11.319
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.16B
Price to Earnings Ratio	-3.43
Price to Sales Ratio	1.32k
Price to Cash Ratio	6.16
Price to Book Ratio	4.33
Dividend Yield	-

Share Statistics

Shares Outstanding	50.78M
Average Volume (1 week)	1.24M
Average Volume (1 Month)	712.17k
52 Week Change	117.48%
52 Week High	47.97
52 Week Low	10.42

More Ratios Coming Soon!

Spyre Therapeutics

BNP PARIBAS EASY FTSE EP...

Rhyolite Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions